Ilias Nasreen A, Xian Hong, Inman Cindi, Martin Wade H
Department of Internal Medicine, Washington University School of Medicine, St Louis Veterans Administration Medical Center, St Louis, MO 63106, USA.
Am Heart J. 2009 Jan;157(1):69-76. doi: 10.1016/j.ahj.2008.09.007. Epub 2008 Nov 1.
Treadmill exercise testing provides prognostic and clinical information that is not available for patients with lower extremity disabilities who undergo pharmacologic stress tests. We sought to determine whether arm ergometer (AXT) exercise capacity in resting metabolic equivalents (METs) and hemodynamic and electrocardiographic responses to AXT are predictors of survival, myocardial infarction (MI), or coronary revascularization, individually or as a composite.
A prospective cohort of 359 veterans aged 63 +/- 11 (SD) years, who were unable or unwilling to perform treadmill exercise, underwent AXT stress testing for clinical reasons between 1997 and 2002 and were followed for 63 +/- 24 months to an end point of death or December 31, 2006. Average annual mortality, MI, revascularization, and combined event rates were 5.2%, 1.7%, 2.2%, and 7.1%, respectively.
By univariate analysis, AXT METs were highly predictive of survival (P < .01; hazard ratio 0.58, 95% confidence interval 0.46-0.70). A greater delta (peak-rest) heart rate, peak exercise systolic blood pressure, and rate pressure product were associated with survival and event-free outcome (all P < .02). A positive exercise electrocardiogram was predictive of death, revascularization, and combined events (all P < .01), and borderline predictive of MI (P = .058). By Wald chi(2) analysis, age, clinical variables, exercise capacity in METs, a positive exercise electrocardiogram, and delta heart rate all had statistically significant incremental prognostic value (P < .05) for survival.
In older veterans with lower extremity disabilities and more comorbidities than most study populations, arm exercise capacity, delta heart rate, and a positive electrocardiogram were independently predictive of survival and/or adverse cardiovascular outcomes.
对于接受药物负荷试验的下肢残疾患者,跑步机运动试验可提供预后和临床信息,但这些信息无法通过其他方式获得。我们试图确定以静息代谢当量(METs)表示的手臂测力计(AXT)运动能力以及AXT时的血流动力学和心电图反应是否分别或综合作为生存、心肌梗死(MI)或冠状动脉血运重建的预测指标。
一个前瞻性队列研究纳入了359名年龄为63±11(标准差)岁的退伍军人,他们无法或不愿意进行跑步机运动,于1997年至2002年间因临床原因接受了AXT负荷试验,并随访63±24个月直至死亡终点或2006年12月31日。平均年死亡率、MI发生率、血运重建率和联合事件发生率分别为5.2%、1.7%、2.2%和7.1%。
单因素分析显示,AXT的METs对生存具有高度预测性(P <.01;风险比0.58,95%置信区间0.46 - 0.70)。更大的心率变化(峰值 - 静息)、运动峰值收缩压和心率血压乘积与生存和无事件结局相关(所有P <.02)。运动心电图阳性可预测死亡、血运重建和联合事件(所有P <.01),对MI的预测接近临界值(P = 0.058)。通过Wald卡方分析,年龄、临床变量、METs运动能力、运动心电图阳性和心率变化对生存均具有统计学显著的增量预后价值(P <.05)。
在下肢残疾且合并症比大多数研究人群更多的老年退伍军人中,手臂运动能力、心率变化和心电图阳性可独立预测生存和/或不良心血管结局。